Navigation Links
PRT054021 in Medical Technology

Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery

...ulants, determined that EXPERT met its objectives: prt054021 appeared effective and safe at the two doses studi... look forward to studying the unique properties of prt054021 in additional clinical trials." About prt054021 - Portola's Factor Xa Inhibitor ...

Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

...tled "Evaluation of the Factor Xa (FXA) Inhibitor, prt054021 (PRT021), against Enoxaparin in Randomized Trial f...0 p.m. (CEST) in the exhibition area. About prt054021 -- Portola's Factor Xa Inhibitor prt054021 is an oral Factor Xa inhibitor, an anticoagulant i...

Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

...replacement (TKR) surgery. Portola expects to move prt054021 into Phase III clinical development in VTE prevent... compare the safety and antithrombotic activity of prt054021 with that of enoxaparin. A steering committee of l... concluded that EXPERT met its objectives and that prt054021 was safe and effective at the doses studied. ...
PRT054021 in other areas

Healthcare Sales & Marketing Network News: Portola Pharmaceuticals ...

Portola Pharmaceuticals Announces Positive Phase II Results for PRT054021 for Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery (HSMN ...

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention ...

Randomized study of PRT054021 40 mg and 15 mg bid vs. enoxaparin 30 mg q12h for ... Drug: PRT054021. Phase II. Study Type: Interventional. Study Design: ...

医药工业研究院_新闻中心

Based on these results, Portola will advance PRT054021 into further clinical testing. ... PRT054021 is an oral Factor Xa inhibitor, an anticoagulant initially being ...

Phase II Study Of Factor Xa Inhibitor Gives Positive Results, Drug ...

... announced positive Phase II data on its lead compound, PRT054021, an oral Factor Xa inhibitor. ... expects to move PRT054021 into Phase III clinical ...

Portola Announces Positive Data on Factor Xa Inhibitor in VTE Trial

Portola Pharmaceuticals has received positive results from EXPERT, a Phase II study of its oral Factor Xa inhibitor, PRT054021, for the prevention of venous ...

Portola Pharmaceuticals, Inc. Announces Positive Phase II EXPERT ...

PRT054021 is an oral Factor Xa inhibitor, an anticoagulant initially being ... In addition, PRT054021 is not excreted in the kidneys and therefore will not ...
Other Tags
(Date:9/22/2014)... 2014 (HealthDay News) -- All sexually active women ... common sexually transmitted infections: chlamydia and gonorrhea, according ... Task Force. The task force noted ... 24 years of age and pregnant women. ... noticeable symptoms. As a result, many infections go ...
(Date:9/22/2014)... New York, New York (PRWEB) September 22, 2014 ... ) filed against Boston Scientific Corp. continue to ... underway in U.S. District Court, Southern District of ... court documents, a new Docket Control Order was ... addresses a number of matters pertaining to the ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... newborn intensive care units (NICU) set up private rooms for ... finds. Researchers at one children,s hospital found that preemies ... when their NICU switched from the traditional "open-bay" layout to ... 22 in the journal Pediatrics , add to evidence ...
(Date:9/22/2014)... Mozes HealthDay Reporter MONDAY, ... American parents are aware of online physician-rating sites, and more ... their children, according to a new national study. The ... -- further suggest that negative online ratings may dissuade parents ... recommended by a neighbor. Conversely, a positive online rating ...
(Date:9/22/2014)... whole eye transplant seems futuristic, if not impossible. ... Department of Defense, researchers at University of California, ... make implantation of an entire, functional eye a ... a holy grail for vision restoration," said Jeffrey ... co-recipient with colleagues at University of Pittsburg Medical ...
Breaking Medicine News(10 mins):Health News:Screen Women for Chlamydia, Gonorrhea, Experts Say 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Boston Scientific Litigation, Bernstein Liebhard LLP Reports 4Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 2Health News:Newborn ICUs With Private Family Rooms Benefit Preemies: Study 3Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Looking ahead: Whole eye transplant under development 2
(Date:9/21/2014)... 2014The story of cowpea (black-eyed peas) is a fascinating ... problemseven more fascinating is the story of the scientist ... The Food Legume of the 21st Century to serve ... use. The book was recently published by the Crop ... of Tropical Agriculture (IITA). , Singh has devoted his ...
(Date:9/21/2014)... recent years, new strains of bacteria have emerged that ... superbugs, including drug-resistant forms of tuberculosis and staphylococcus, infect ... least 23,000. Despite the urgent need for new treatments, ... in the past decade. , MIT engineers have now ... a gene-editing system that can disable any target gene, ...
(Date:9/21/2014)... team of Stanford researchers has developed a protein therapy ... break away from original tumor sites, travel through the ... the body. , This process, known as metastasis, can ... "The majority of patients who succumb to cancer fall ... Cochran, an associate professor of bioengineering who describes a ...
Breaking Biology News(10 mins):Battling superbugs 2Battling superbugs 3Battling superbugs 4Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4
Other Contents